Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Others simply want additional metabolic support while continuing to focus on exercise, nutrition, sleep, and strength training
The appropriate amount varies by individual and the amount of alcohol consumed
Also published in the New England Journal of Medicine in 2022, the SURMOUNT-1 trial demonstrated that tirzepatide at the 15 mg dose produced an average weight loss of 22.5% of body weight over 72 weeks approaching results typically seen with bariatric surgery (Jastreboff et al., 2022, PMID: 35658024)
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the diabetes prevention program outcome study and the daqing diabetes prevention outcome study
For researchers studying metabolic syndrome, Retatrutide offers the potential to address multiple components simultaneously
